Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Innovation In OTC Switches Takes Multimedia Approach In US FDA Draft Guidance

Executive Summary

Sponsors can point consumers to video displays, website information and mobile apps to help them choose products that have been switched from Rx to OTC. Draft guidance on innovative switch applications to be followed by rule-making in near future.

Advertisement

Related Content

Perrigo's OTC Core Could Expand To Include National Brands
Rulemaking For OTC Switch Process Changes Pushed To 2019
Room For Innovative Switches Could Lurk In Existing FDA Framework
FDA Encourages Novel Switch Ideas, Though NSURE Remains Unsure
FDA Aims To “NSURE” Clarity About New Paradigm For OTC Switches
FDA To Tackle Critical Generics Issue In Switch Paradigm Debate

Topics

Advertisement
UsernamePublicRestriction

Register

PS123511

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel